Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Jun-24 4:18 PM View:  | BioCryst Pharmaceuticals Inc. (BCRX) | 12-Jun-24 | Grant | 6,820 | -- | -- | 23% 29.61K to 36.43K | |
| 15-Jun-23 4:28 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 13-Jun-23 | Grant | 16,745 | -- | -- | 130% 12.87K to 29.61K | |
| 09-Jun-22 4:43 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 07-Jun-22 | Grant | 12,866 | -- | -- | 100% 0 to 12.87K | |
| 20-Apr-22 4:23 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 18-Apr-22 | Option Exercise | 5,000 | $3.32 | $16,600.00 | 100% 0 to 5.0K | |
| 20-Apr-22 4:23 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 18-Apr-22 | Option Sale | 5,000 | $11.04 | $55,200.00 | (100%) 5.0K to 0 | |
| 16-Feb-22 4:25 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 15-Feb-22 | Option Exercise | 5,000 | $3.32 | $16,600.00 | 100% 0 to 5.0K | |
| 16-Feb-22 4:25 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 15-Feb-22 | Option Sale | 5,000 | $18.50 | $92,500.00 | (100%) 5.0K to 0 | |
| 17-Nov-21 4:27 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 15-Nov-21 | Option Exercise | 5,000 | $3.32 | $16,600.00 | 100% 0 to 5.0K | |
| 17-Nov-21 4:27 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 15-Nov-21 | Market Option Sale | 5,000 | $12.27 | $61,350.00 | (100%) 5.0K to 0 | |
| 17-Sep-21 4:31 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 15-Sep-21 | Option Exercise | 5,000 | $2.63 | $13,150.00 | 100% 0 to 5.0K | |
| 17-Sep-21 4:31 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 15-Sep-21 | Market Option Sale | 5,000 | $15.06 | $75,300.00 | (100%) 5.0K to 0 | |
| 14-Sep-21 4:14 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 10-Sep-21 | Option Exercise | 71,000 | $2.86 | $202,710.00 | 2367% 3.0K to 74.0K | |
| 14-Sep-21 4:14 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 10-Sep-21 | Market Option Sale | 71,000 | $15.09 | $1,071,390.00 | (96%) 74.0K to 3.0K | |
| 14-Sep-21 4:14 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 10-Sep-21 | Market Sale | 3,000 | $15.09 | $45,270.00 | (100%) 3.0K to 0 | |
| 19-Jul-21 4:39 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 15-Jul-21 | Option Exercise | 5,000 | $2.63 | $13,150.00 | 167% 3.0K to 8.0K | |
| 19-Jul-21 4:39 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 15-Jul-21 | Market Option Sale | 5,000 | $15.69 | $78,450.00 | (62%) 8.0K to 3.0K | |
| 26-May-21 4:12 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 24-May-21 | Option Exercise | 6,667 | $2.63 | $17,534.20 | 222% 3.0K to 9.67K | |
| 26-May-21 4:12 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 24-May-21 | Market Option Sale | 6,667 | $13.90 | $92,671.30 | (69%) 9.67K to 3.0K | |
| 12-May-21 10:00 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 10-May-21 | Market Sale | 7,000 | $12.70 | $88,900.00 | (70%) 10.0K to 3.0K | 2% |
| 22-Aug-18 6:46 PM View: | Theravance Inc. (INVA) | 21-Aug-18 | Market Sale (Planned) | 8,000 | $14.10 | $112,840.00 | (3%) 293.48K to 285.48K | 13% |
| 22-Aug-18 6:46 PM View: | Theravance Inc. (INVA) | 20-Aug-18 | Payment of Exercise | 5,680 | $14.08 | $79,974.40 | (2%) 299.16K to 293.48K | 12% |
| 22-May-18 7:52 PM View: | Theravance Inc. (INVA) | 21-May-18 | Market Sale | 8,000 | $14.40 | $115,202.00 | (3%) 307.16K to 299.16K | 14% |
| 22-May-18 7:52 PM View: | Theravance Inc. (INVA) | 20-May-18 | Payment of Exercise | 4,682 | $14.59 | $68,310.40 | (2%) 309.92K to 305.24K | 15% |
| 06-Mar-18 4:14 PM View: | Theravance Inc. (INVA) | 02-Mar-18 | Grant | 74,444 | -- | -- | 32% 235.47K to 309.92K | |
| 22-Feb-18 4:23 PM View: | Theravance Inc. (INVA) | 21-Feb-18 | Market Sale (Planned) | 8,000 | $16.51 | $132,100.00 | (3%) 243.47K to 235.47K | 25% |
| 22-Feb-18 4:23 PM View: | Theravance Inc. (INVA) | 20-Feb-18 | Payment of Exercise | 15,500 | $16.44 | $254,820.00 | (6%) 258.97K to 243.47K | 25% |
| 22-Nov-17 4:52 PM View: | Theravance Inc. (INVA) | 21-Nov-17 | Market Sale (Planned) | 5,215 | $13.26 | $69,145.20 | (2%) 263.87K to 258.65K | 7% |
| 22-Nov-17 4:52 PM View: | Theravance Inc. (INVA) | 20-Nov-17 | Payment of Exercise | 3,358 | $13.17 | $44,224.90 | (1%) 267.22K to 263.87K | 6% |
| 22-Aug-17 4:38 PM View: | Theravance Inc. (INVA) | 20-Aug-17 | Payment of Exercise | 2,886 | $12.28 | $35,440.10 | (1%) 270.11K to 267.22K | (< 1%) |
| 23-May-17 4:15 PM View: | Theravance Inc. (INVA) | 20-May-17 | Payment of Exercise | 2,228 | $11.86 | $26,424.10 | (< 1%) 272.34K to 270.11K | (4%) |
| 22-Feb-17 4:31 PM View: | Theravance Inc. (INVA) | 20-Feb-17 | Payment of Exercise | 5,355 | $12.04 | $64,474.20 | (2%) 275.19K to 269.84K | (3%) |
| 19-Jan-17 8:26 PM View: | Theravance Inc. (INVA) | 17-Jan-17 | Grant | 106,718 | -- | -- | 63% 168.47K to 275.19K | |
| 22-Nov-16 5:39 PM View: | Theravance Inc. (INVA) | 20-Nov-16 | Payment of Exercise | 1,273 | $10.91 | $13,888.40 | (< 1%) 169.75K to 168.47K | (13%) |
| 23-Aug-16 6:57 PM View: | Theravance Inc. (INVA) | 20-Aug-16 | Payment of Exercise | 1,939 | $11.79 | $22,860.80 | (1%) 171.4K to 169.46K | (5%) |
| 20-May-16 7:51 PM View: | Theravance Inc. (INVA) | 20-May-16 | Payment of Exercise | 1,276 | $11.09 | $14,150.80 | (< 1%) 172.68K to 171.4K | (11%) |
| 23-Feb-16 6:57 PM View: | Theravance Inc. (INVA) | 19-Feb-16 | Payment of Exercise | 5,376 | $12.28 | $66,017.30 | (3%) 175.55K to 170.18K | (< 1%) |
| 19-Jan-16 4:08 PM View: | Theravance Inc. (INVA) | 14-Jan-16 | Grant | 92,587 | -- | -- | 112% 82.97K to 175.55K | |
| 09-Jan-15 4:32 PM View: | Theravance Inc. (INVA) | 07-Jan-15 | Grant | 71,429 | -- | -- | 714% 10.0K to 81.43K | |
| 23-Jun-14 7:04 PM View: | Theravance Inc. (INVA) | 19-Jun-14 | Grant | 10,000 | -- | -- | 100% 0 to 10.0K | |
| 01-Apr-14 10:37 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 31-Mar-14 | Option Exercise | 4,000 | $1.71 | $6,840.00 | 67% 6.0K to 10.0K | |
| 13-Nov-13 4:25 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 12-Nov-13 | Market Purchase | 3,000 | $6.19 | $18,570.00 | 100% 3.0K to 6.0K | 22% |
| 06-Mar-13 4:45 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 05-Mar-13 | Market Purchase | 3,000 | $1.23 | $3,690.00 | 100% 0 to 3.0K | 513% |
| 16-May-11 10:00 PM View: | Inspire Pharmaceuticals, Inc. (ISPH) | 13-May-11 | Disposition (change in control) | 1,099 | $5.00 | $5,495.00 | (100%) 1.1K to 0 | (< 1%) |
| 07-Jun-10 4:56 PM View: | Inspire Pharmaceuticals, Inc. (ISPH) | 03-Jun-10 | Payment of Exercise | 493 | $5.82 | $2,869.26 | (31%) 1.59K to 1.1K | 8% |
| 07-Jun-10 4:56 PM View: | Inspire Pharmaceuticals, Inc. (ISPH) | 03-Jun-10 | Option Exercise | 1,592 | -- | -- | 100% 0 to 1.59K | |
| 06-Apr-10 4:02 PM View: | ZIOPHARM Oncology, Inc. (TCRT) | 05-Apr-10 | Grant | 25,000 | -- | -- | 100% 0 to 25.0K |